semaglutide adolescent obesity trial 2022 Half of children given 'skinny jab' no longer clinically obese, study finds | Semaglutide Effective for Weight Loss

(PubMed) Cotroneo AM, Castagna A, Putignano S, et al

So overall, we would think, but don't know yet because we don't have the results, that this is a group of patients that would have a fairly low event rate for major adverse cardiovascular events, which is what's being looked at in Select and as a secondary endpoint, these kidney outcomes

Complicated unstable cardiovascular disease, severe kidney disease, history of recurrent pancreatitis, gastroparesis, or multiple complex medication regimens may need more intensive medical supervision than telehealth provides

Regulation of the hypothalamic-pituitary-adrenocortical stress response

This often means better coverage for Wegovy patients